default author photo

Li Xie

Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases

Xi’an

China

  • Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases

SCHOLARLY PAPERS

3

DOWNLOADS

294

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

mRNA-Based COVID-19 Booster Vaccination is Highly Effective And Cost-Effective In Australia

Downloads 124 (580,653)

mRNA-Based COVID-19 Booster Vaccination is Highly Effective And Cost-Effective In Australia

Number of pages: 14 Posted: 09 May 2022
Rui Li, Hanting Liu, Christopher K. Fairley, Jason Ong, Yuming Guo, Zhuoru Zou, Li Xie, Guihua Zhuang, Yan Li, Mingwang Shen and Lei Zhang
Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Alfred Health - Melbourne Sexual Health Centre, Alfred Health - Melbourne Sexual Health Centre, Monash University - Department of Epidemiology and Preventive Medicine, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Mount Sinai Health System - Department of Population Health Science and Policy, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases and Alfred Health - Melbourne Sexual Health Centre
Downloads 85 (779,641)

Abstract:

Loading...

COVID-19, Booster, Cost-effective analysis, Markov model, Australia

Mrna-Based COVID-19 Booster Vaccination is Highly Effective And Cost-Effective In Australia

Number of pages: 16 Posted: 05 Aug 2022
Rui Li, Hanting Liu, Christopher K. Fairley, Jason Ong, Yuming Guo, Pengyi Lu, Zhuoru Zou, Li Xie, Guihua Zhuang, Yan Li, Mingwang Shen and Lei Zhang
Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Alfred Health - Melbourne Sexual Health Centre, Alfred Health - Melbourne Sexual Health Centre, Monash University - Department of Epidemiology and Preventive Medicine, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Mount Sinai Health System - Department of Population Health Science and Policy, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases and Alfred Health - Melbourne Sexual Health Centre
Downloads 39 (1,224,220)

Abstract:

Loading...

Keywords: COVID-19, Booster, Cost-effective analysis, Markov model, Australia

2.

Cost-Effectiveness Analysis of BNT162b2 COVID-19 Booster Vaccination in the United States

Number of pages: 15 Posted: 14 Dec 2021
Rui Li, Hanting Liu, Christopher K. Fairley, Zhuoru Zou, Li Xie, Xinghui Li, Mingwang Shen, Yan Li and Lei Zhang
Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Alfred Health - Melbourne Sexual Health Centre, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Mount Sinai Health System - Department of Obstetrics, Gynaecology, and Reproductive Science, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Mount Sinai Health System - Department of Population Health Science and Policy and Alfred Health - Melbourne Sexual Health Centre
Downloads 102 (679,608)

Abstract:

Loading...

COIVD-19, Booster vaccination, Cost-effectiveness, Population incidence, United States

3.

Determining the Initiation Time of Peripartum Antiviral Prophylaxis Among Pregnant Women with Chronic Hepatitis B Infection: A Mathematical Modelling Study Based on Real-World Clinical Data

Number of pages: 25 Posted: 13 Feb 2024
Shihao He, Naijuan Yao, Rui Li, Jing Wang, Wenting Zhong, Jinyan Wang, Huihui Wang, Li Xie, Guihua Zhuang, Tianyan Chen, Lei Zhang and Mingwang Shen
Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Xi'an Jiaotong University (XJTU) - Shaanxi Clinical Research Center of Infectious Diseases, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, North Minzu University, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases, Xi'an Jiaotong University (XJTU) - Department of Infectious Diseases, Alfred Health - Melbourne Sexual Health Centre and Xi'an Jiaotong University (XJTU) - China-Australia Joint Research Center for Infectious Diseases
Downloads 68 (891,180)

Abstract:

Loading...

chronic hepatitis B infection, prevention of mother-to-child transmission, peripartum antiviral prophylaxis, mathematical modelling, tenofovir disoproxil fumarate, telbivudine